Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nchuang
    Junior Member
    • Oct 2018
    • 1

    #1

    Targeted sequencing workflow?

    I have a non-barcoded multiple samples pool of long amplicons sequenced on RSII. I'm trying to figure out the correct workflow. My goal is to perform variant calling.

    After reading on this for 2 days this is what I have pieced together:
    1. bax2bam conversion
    2. blasr alignment all reads to my reference
    3. quiver/arrow polishing
    4. LAA generate consensus reads
    5. blasr (or bowtie even?) to align consensus reads to reference
    6. minorseq for variant calling

    Does this look correct?

    I initially thought CCS subreads would be a good trick to demultiplex my multiple samples (about 70? I don't know why it wasn't barcoded in the first place, I didn't handle that part). However my amplicons are all >5kb and I think I read CCS subreads are more useful for small amplicons (makes sense if these are able to run longer). I just want to see the extent of variation (primarily small variation) in this population of 70 samples.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...